Skip to content

Comparison of Ultrasound-guided Central Venous Catherterization Via the Lower Internal Jugular Vein or the Subclavian Vein

Comparison of Ultrasound-guided Central Venous Catherterization Via the Lower Internal Jugular Vein or the Subclavian Vein

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03162757
Acronym
JI vs SC
Enrollment
210
Registered
2017-05-22
Start date
2017-01-26
Completion date
2018-07-25
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Venous Access

Brief summary

The aim of this pilot study is to establish the success rate of catheterization of the lower jugular vein and the subclavian vein under ultrasound guidance in real time. The purpose is to compare the two techniques and to determine the best design for a full study (superiority, non-inferiority). This is a 2-arm randomized control study. The randomization ensures the comparability of the groups and allows evaluation of the feasibility and potential bias for further comparative studies.

Interventions

PROCEDURECentral venous catheterization

Central venous catheterization via either internal jugular vein or subclavian vein up to a maximum of two attempts.

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient has been, or will be, informed as soon as their state of health allows them to be entered into the study of its objectives, constraints and the patient's rights * The patient have given their free and informed consent and signed the consent form * The patient must be insured or a beneficiary of a health insurance plan * The patient is over 18 years old * The patient needs a venous catheter in the superior vena cava

Exclusion criteria

* The patient is already participating in another interventional study that could influence the results of this study * The patient has participated in another interventional study within the previous 3 months that could influence the results of this study * The patient is in a period of exclusion determined by a previous study * The patient is under judicial protection or is an adult under guardianship * The patient refuses to sign the consent form * Non-echogenic patient * Moribund patient * The patient has a contra-indication to one or other of the approaches: infection of the insertion zone, known thrombosis, severely dyspneic * Patient has severe coagulation problems: PT\<40%, platelets\<50 000 and curable anticoagulation with antiXa \> 0.5 or INR\>3. * Patient has a congenital or acquired deformation at the entry site

Design outcomes

Primary

MeasureTime frameDescription
Successful placement catheter from a maximum of two attemptsDuring procedureBinary yes/no

Secondary

MeasureTime frameDescription
arterial puncturewithin 1 hourbinary yes/no
failurewithin 1 hourbinary yes/no
arrhythmiawithin 1 hourbinary yes/no
abberant placement of catheter1 daybinary yes/no
catheter infectionat removal of catheter; on average 6.5 daysbinary yes/no
catheter colonizationat removal of catheter; on average 6.5 daysbinary yes/no
mediastinal hematoma1 daybinary yes/no
Pneumothorax1 daybinary yes/no
success at first attemptwithin 1 houryes/no
time between puncture until insertion of guidewithin 1 hourmeasure in seconds
clinical variables associated with failure of the techniqueswithin 24 hours
number of dressingsover length of hospitalization; maximum 40 daysper day
nurse-rated satisfaction at each dressing replacementover length of hospitalization; maximum 40 daysscore 0-10
haemothorax1 daybinary yes/no
thrombosisuntil removal of catheter; on average 6.5 daysbinary yes/no

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026